Whalegun

Insider trades

Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.

Open-market buys
923 trades
$2B in total
Open-market sales
1,042 trades
$2.3B in total
Insiders filing
464 insiders
Last 7 days
Companies with several buyers
26
Last 7 days
Verrica Pharmaceuticals VRCA
Trade type
Director
Verrica PharmaceuticalsVRCA
Open-market buy25/11/2525/11/254,126,142 sh2 trades$4.24avg.$17,494,842.08No record
John J. KirbyInterim CFO
Verrica PharmaceuticalsVRCA
Open-market buy25/11/2525/11/253,536 sh$4.24$14,992.64+65.2%
Noah L. RosenbergCmo
Verrica PharmaceuticalsVRCA
Open-market buy25/11/2525/11/252,357 sh$4.24$9,993.68No record
Jayson RiegerCEO and President
Verrica PharmaceuticalsVRCA
Open-market buy25/11/2525/11/2594,311 sh$4.24$399,878.64+106.8%
David ZawitzCOO
Verrica PharmaceuticalsVRCA
Open-market buy25/11/2525/11/2510,000 sh$4.24$42,400+90.9%
Christopher G. HayesChief Legal Officer
Verrica PharmaceuticalsVRCA
Open-market sale25/03/1725/03/184,315 sh$0.65$2,804.75−2.4%
Director
Verrica PharmaceuticalsVRCA
Open-market buy24/11/2224/11/2622,921,348 sh2 tradesNo stated valueNo stated valueNo record
John A. Stalfort IIIDirector
Verrica PharmaceuticalsVRCA
Open-market buy24/11/2224/11/261,123,595 shIn footnoteNo stated value+160.5%
Jayson RiegerCEO and President
Verrica PharmaceuticalsVRCA
Open-market buy24/11/2224/11/26280,898 shIn footnoteNo stated value+50.9%
Chief Medical Officer
Verrica PharmaceuticalsVRCA
Open-market sale24/08/26–24/08/2724/08/2813,489 sh2 trades$2.61avg.$35,160.54−12.5%
President and CEO
Verrica PharmaceuticalsVRCA
Open-market sale24/08/26–24/08/2724/08/2834,000 sh2 trades$2.61avg.$88,635.8−13.6%
Chief Commercial Officer
Verrica PharmaceuticalsVRCA
Open-market sale24/08/26–24/08/2724/08/2833,702 sh2 trades$2.61avg.$87,848.72−31.6%
Chief Legal Officer
Verrica PharmaceuticalsVRCA
Open-market sale24/08/26–24/08/2724/08/2835,713 sh2 trades$2.61avg.$93,090.58−25.2%
CFO
Verrica PharmaceuticalsVRCA
Open-market sale24/08/26–24/08/2724/08/2829,719 sh2 trades$2.61avg.$77,472.74−39.9%
Chief Medical Officer
Verrica PharmaceuticalsVRCA
Open-market sale24/07/22–24/07/2324/07/2318,507 sh2 trades$7.06avg.$130,652.54−14.7%
President and CEO
Verrica PharmaceuticalsVRCA
Open-market sale24/07/22–24/07/2324/07/2332,623 sh2 trades$7.06avg.$230,306.06−11.5%
Chief Commercial Officer
Verrica PharmaceuticalsVRCA
Open-market sale24/07/22–24/07/2324/07/2325,576 sh2 trades$7.06avg.$180,557.36−19.3%
Chief Legal Officer
Verrica PharmaceuticalsVRCA
Open-market sale24/07/22–24/07/2324/07/2321,740 sh2 trades$7.06avg.$153,477.12−13.3%
10% Owner
Verrica PharmaceuticalsVRCA
Open-market buy23/12/27–23/12/2923/12/29321,616 sh3 trades$7.17avg.$2,305,132.24+4.7%
10% Owner
Verrica PharmaceuticalsVRCA
Open-market buy23/12/27–23/12/2923/12/29321,616 sh3 trades$7.17avg.$2,305,132.24+4.7%